Initiative against diabetes amputations launched:
This article was originally published in Clinica
The diabetes alliance of Boehringer Mannheim and Eli Lilly has launched a footcare initiative aimed at reducing the number of diabetes-related amputations. One in six of the more than 100 million diabetics worldwide suffers from non-healing leg and foot ulcers and 5-10% of diabetic foot ulcers result in amputations. The initiative will develop guidelines covering prevention, patient education, diagnosis, management, pathogenesis and the training of healthcare organisations and professionals.